Deal strengthens next-gen PEEK interbody implant development
Medtronic (NYSE: MDT) has acquired nano surface technology assets and IP rights from Nanovis, including Sites Medical’s OsteoSync titanium pads, to enhance its PEEK interbody fusion devices.
Key Highlights:
- Technology: Nanovis’ bone-growth nanotechnology enhances implant fixation via osseointegration.
- Application: Accelerates and improves bone fusion in spinal implants.
- Medtronic’s Goal: Strengthen its Infuse bone graft platform for spine, oral-maxillofacial, and orthopedic trauma procedures.
- Financial Terms: Undisclosed.
“This collaboration is a testament to the significance of our nano surface technology and its value to patients,” said Nanovis CEO Brian More.
Follow MEDWIRE.AI for more on spinal implant innovations.
